JG
MDGL icon

Jefferies Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jefferies Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,200
Closed -$271K – 1790
2021
Q4 		$271K Buy
+3,200
New +$263K ﹤0.01% 1313
2019
Q4 		– Sell
-10,700
Closed -$923K – 2807
2019
Q3 		$923K Buy
10,700
+4,700
+78% +$441K 0.01% 1555
2019
Q2 		$629K Sell
6,000
-90,200
-94% -$9.66M ﹤0.01% 1547
2019
Q1 		$12.1M Sell
96,200
-35,300
-27% -$4.39M 0.1% 167
2018
Q4 		$14.8M Buy
131,500
+60,200
+84% +$9.32M 0.12% 130
2018
Q3 		$15.3M Buy
+71,300
New +$17.9M 0.1% 176
2013
Q4 		– Sell
-1,969
Closed -$435K – 2100
2013
Q3 		$435K Buy
+1,969
New +$419K ﹤0.01% 1252

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jefferies Group's MDGL Position: Q3 2021 in Review

Jefferies Group sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2021, closing a stake of 5,023 shares — an estimated $489K sold.

Jefferies Group first reported a position in MDGL in Q3 2013 and held it in 19 quarters. The position peaked at $6.29M in Q1 2015. 133 funds tracked by Wall St. Rank hold MDGL as of Q3 2021.

  • Jefferies Group reported no remaining Madrigal Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 5,023 Madrigal Pharmaceuticals shares in Q3 2021, an estimated $489K.
  • Jefferies Group first reported a position in Madrigal Pharmaceuticals in Q3 2013 and held it in 19 quarters.
  • Jefferies Group's Madrigal Pharmaceuticals position peaked at $6.29M in Q1 2015.
  • 133 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.